Prevalence of human papillomavirus infection in women in Portugal the CLEOPATRE Portugal study

International Journal of Gynecological Cancer

Volumn 21, Issue 6, 2011, Pages 1150-1158

  Pista, Angela ^a   De Oliveira, Carlos Freire ^b   Cunha, Maria João ^c   Paixao, Maria Teresa ^a   Real, Odete ^d  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c Sanofi Pasteur MSD   (Portugal)

^d Cytopathology Laboratory   (Portugal)

Author keywords

Cytology; HPV genotyping; HPV prevalence; Human papillomavirus; Portugal

Indexed keywords

WART VIRUS VACCINE;

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CYTOLOGY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 44; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 71; HUMAN PAPILLOMAVIRUS TYPE 72; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 81; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 83; HUMAN PAPILLOMAVIRUS TYPE 84; HUMAN PAPILLOMAVIRUS TYPE 85; HUMAN PAPILLOMAVIRUS TYPE 89; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX DISEASE; VACCINATION; VIRUS EXAMINATION;

ADOLESCENT; ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PORTUGAL; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 83055169884     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31821dd3b2     Document Type: Article

References (25)

1. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(suppl 3):35Y41.
2. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):11Y25.
3. Bosch FX, de Sanjosé S. Chapter 1: Human papillomavirus and cervical cancerVburden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3Y13.
4. Bernard HU, Burk RD, Chen Z, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70Y79.
5. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518Y527. (Pubitemid 36159887)
6. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research in Cancer; 2010. Available at: . Accessed November 8, 2010.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12Y19. (Pubitemid 29406813)
8. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621Y362.
9. De Vuyst H, Clifford G, Li N, et al. HPV infection in Europe. Eur J Cancer. 2009;45:2632Y2639.
10. Henry MR. The Bethesda System 2001: an update of new terminology for gynecologic cytology. Clin Lab Med. 2003;23:585Y603. (Pubitemid 37175546)
11. Pista A, Verdasca N, Oliveira A. Clinical performance of the CLART Human Papillomavirus 2 assay compared with the Hybrid Capture 2. J Med Virol. 2011;82:272Y276.
12. Bouvard V, Baan R, Straif K, et al. A review of human carcinogensVPart B. Biological agents. Lancet Oncol. 2009;10:321Y322.
13. Instituto Nacional de Estatística. 2007. Available at: http://www.ine.pt. Accessed November 8, 2010.
14. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). 2010. Available at: http://www.who.int/hpvcentre. Accessed November 8, 2010.
15. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine. 2006;24(suppl 1):1Y15.
16. Smith JS, Melendy A, Rana RK, et al. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008;43(suppl 4):5Y25.
17. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119:2677Y2684. (Pubitemid 44691325)
18. Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer. 2008;123:1864Y1870.
19. Hibbitts S, Jones J, Powell N, et al. Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer. 2008;99:1929Y1933.
20. Castellsagué X, Rémy V, Puig-Tintoré LM, et al. Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain. J Low Genit Tract Dis. 2009;13:38Y45.
21. Rossi PG, Ricciardi A, Cohet C, et al. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy. BMC Public Health. 2009;9:71.
22. Prétet JL, Jacquard AC, Saunier M, et al. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study. Gynecol Oncol. 2008;110:179Y184.
23. Menegazzi P, Barzon L, Palù G, et al. Human papillomavirus type distribution and correlation with cyto-histological patterns in women from the South of Italy. Infect Dis Obstet Gynecol. 2009;2009:198425.
24. Kovács K, Varnai AD, Bollmann M, et al. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J Med Virol. 2008;80:1814Y1823.
25. Cuschieri KS, Cubie HA, Whitley MW, et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol. 2004;57:68Y72. (Pubitemid 38091314)